Amilpar - Relevant Fact

Tuesday, December 22, 2009 Drug News J E 4

RIO DE JANEIRO, Dec. 21 Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR ; Reuters: AMIL3.SA), the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction nš 358/02, and in addition to the Relevant Facts released on November 19, 2009, December 2 and 9, 2009, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. will proceed only with the mandatory public offer for the acquisition of shares issued by Medial Saude S.A. due to the change of control of this company (Tag Along) and will not, at the moment, promote public offer for the following purposes (a) exit of the Bovespa's Novo Mercado and (b) cancellation of the register of public company (delisting) of Medial Saude S.A.

Amilpar will keep the market and its shareholders informed about the conclusion of the above mentioned offer.

To access the Relevant Fact visit our website at

IR Contact ---------- Erwin Kleuser ------------- Investor Relations Officer -------------------------- Phone: +55 (21) 3805-1155 ------------------------- ------------------ ---------------------

SOURCE Amilpar


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Flipping for Phonics(TM) Helps Spread Cheer To Mil...
American Pacific to Release Financial Results and ...